Encrypted login | home

Program Information

What Is the IROC Roster?

J Lowenstein

J Lowenstein*, P Holguin , D Followill , UT MD Anderson Cancer Center, Houston, TX


SU-I-GPD-P-15 (Sunday, July 30, 2017) 3:00 PM - 6:00 PM Room: Exhibit Hall

Purpose: To inform institutions what the IROC roster is and how it will impact those institutions participating in NCTN funded trials.

Methods: CTEP has made the decision to track all radiation (RT) and imaging (DI) treatment institutions which participate in NCTN trials. These institutions may or may not be patient enrolling sites. These institutions are being pulled from the IROC Houston database, IROC Philadelphia DI database, as well as from questionnaires at the time of credentialing. These institutions are being assigned a unique identifier called the Research Treating Facility (RTF) number and treatment status of RT only, Imaging only or RT/DI by IROC Houston which is then being populated into NCI and CTSU’s databases. Institution information is gathered using an RT or DI facility questionnaire sent to institutions participating in NCTN trials.

Results: Web services have or are being developed to automate the exchange of institution information between IROC Houston, IROC PHL DI and NCI/CTSU. RT and DI credentialing information will also be exchanged between the two IROC centers and the NCI’s Regulatory Support System (RSS). Being on the IROC roster will enable enrolling institution to determine which institutions are credentialed for a trial so they know where they can send a patient to be treated. For those institutions who provide Imaging/RT for several enrolling sites being on the IROC roster will make it possible for the institution to upload the data for a specific patient case to RAVE or TRIAD for each patient.

Conclusion: The intent of the IROC Roster is to track treating facilities on NCTN trials as well as streamline the process of uploading data for each patient treated at an institution but enrolled at a different institution.

Funding Support, Disclosures, and Conflict of Interest: This work was supported by PHS grant CA180803 awarded by NCI, DHHS.

Contact Email: